Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

EU flag

Three cancer immunotherapies amongst new CHMP approvals

BMS’ Evotaz also amongst eight new medicine recommendations

- PMLiVE

The interactive healthcare environment

It’s no secret that communications in consumer health are changing. Consumers are increasingly keen to interact with brands they know and trust - posing a challenge to traditional ways of...

Webinar: The right e-detailing content for rich data

Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too.

Anthill Agency

- PMLiVE

Clinical research in children lagging, says report

Report found children are missing out on treatment advances that are helping adults

- PMLiVE

Amgen decision on brodalumab unsettles anti-IL-17 class

Move made following data found linking the drug to suicidal thoughts

- PMLiVE

AZ escapes censure over cancer tweet

Firm did not breach UK’s Code of Practice over survival statistics post

- PMLiVE

Disappointment for pharma with new Cancer Drugs Fund list

Bayer the only firm to win a reprieve from the CDF drug cull

- PMLiVE

PatientsLikeMe names Jason Johnson as head of R&D

Will also be an executive vice president

- PMLiVE

EMA prepares to launch medical literature monitoring service

Will screen documents for 400 active substance groups

EISAI

Eisai to share clinical trial data via external website

Company aims to further promote transparency in the industry

Can patient-centricity work for pharma?

Challenges remain for companies wanting to integrate a patient-centric strategy into their business model

- PMLiVE

New health ministers and re-appointments after reshuffle

Industry sees both continuity and change after the UK’s General Election

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links